Secondary Prevention of Ischemic Stroke: Updated Guidelines From AHA/ASA

Medicine & Life Sciences

• American Heart Association 100%
• Secondary Prevention 98%
• Stroke 68%
• Guidelines 64%
• Warfarin 33%
• Risk Reduction Behavior 18%
• eicosapentaenoic acid ethyl ester 16%
• Carotid Stenosis 15%
• Ticagrelor 12%
• Aspirin 12%
• Ezetimibe 12%
• Tobacco Smoke Pollution 11%
• Atorvastatin 11%
• Carotid Endarterectomy 10%
• Infliximab 10%
• Clopidogrel 10%
• Endocarditis 9%
• Hyperlipidemias 9%
• Carotid Arteries 8%
• Exercise 8%
• Blood Pressure 8%
• Drinking 8%
• LDL Cholesterol 8%
• Dissection 7%
• Weight Loss 7%
• Pathologic Constriction 7%
• Antithrombin III Deficiency 7%
• Alcohols 6%
• Intracranial Arteriosclerosis 6%
• Proprotein Convertase 9 6%
• Fibromuscular Dysplasia 6%
• Activated Protein C Resistance 6%
• Sodium-Glucose Transport Proteins 6%
• tocilizumab 6%
• Circle of Willis 6%
• Sickle Hemoglobin 6%
• Moyamoya Disease 6%
• Fontan Procedure 6%
• Mediterranean Diet 5%
• Therapeutics 5%
• Hypertension 5%
• Giant Cell Arteritis 5%
• R Factors 5%
• Protein S 5%
• Heart Neoplasms 5%
• Hydroxyurea 5%
• Antiphospholipid Syndrome 5%
• Heart-Assist Devices 5%
• Methamphetamine 5%
• Vertebral Artery 5%
• Prothrombin 5%
• Glucagon-Like Peptide 1 5%
• International Normalized Ratio 5%
• Hypertriglyceridemia 5%
• Intracranial Hemorrhages 5%
• Protein C 5%
• Factor VIII 5%
• Transient Ischemic Attack 5%
• Risk Management 5%
• Sickle Cell Anemia 4%
• Metformin 4%
• Drug Users 4%
• Embolism 4%
• Smoking Cessation 4%
• Cocaine 4%
• Cardiology 4%
• Cardiomyopathies 4%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 4%
• Methotrexate 4%
• Blood Transfusion 4%
• Alcohol Drinking 4%
• Glucocorticoids 4%
• Atrial Fibrillation 4%
• Heart Ventricles 4%
• Sodium 3%
• Heart Diseases 3%
• Hemoglobins 3%
• Triglycerides 3%
• Thrombosis 3%
• Myocardial Infarction 3%
• Obesity 3%
• Odds Ratio 2%
• Equipment and Supplies 2%
• Antibodies 2%
• Pharmaceutical Preparations 1%
• Neoplasms 1%